Arcadia Biosciences, Inc. (NASDAQ:RKDA)
Arcadia Biosciences Tumbling, Keep an Eye on This Stock
Financial specialists have been inquiring about shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) after the stock moved – 0.58%, hitting the $1.70 value point taking after an exchange. Over the previous year, Arcadia Biosciences, Inc’s. stock was – up 43.75%. In the course of the most recent seven days of the month, it was – 11.40%, -23.66% over the three months, and -32.68% for the past half-year.
Arcadia Biosciences, Inc., incorporated on February 17, 2015, is an agricultural biotechnology trait company. The Firm develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.
The organization’s loss from operations was $4.3 million in the second quarter of 2016 contrasted with $3.5 million in the same period of 2015. Net loss inferable from regular stockholders in the second quarter of 2016 was $4.6 million, steady with the practically identical period in 2015.
For the first half of 2016, loss from operations was $9.2 million contrasted with a loss from operations for the same portion of 2015 of $7.3 million. Net loss owing to basic stockholders for the first half of 2016 was $9.7 million, a change of 20% over the same period loss of $12.3 million in last year.
“Utopia is all around situated to convey long haul esteem for producers and purchasers around the world,” said Raj Ketkar, president and CEO, who joined the organization in late May. “We have gained important ground this quarter, and we will keep on focusing on the close term openings in our portfolio while improving how we contribute our assets, building key organizations and propelling our late-arrange items towards commercialization.”